PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Antibiotic Research UK launches small research grants programme

York-based charity Antibiotic Research UK (ANTRUK) has launched a new small research grants programme in a bid to fund research into antibiotics and antibiotic resistance.
The scheme – which is the charity’s largest grants programme to date – will award one grant of up to £50,000 and six grants of up to £25,000 each.
These grants should focus on antibiotic resistance, new antibiotic therapies, health and societal impact of antibiotic resistance or antibiotic stewardship.
Applications to the scheme will be reviewed by independent external assessors and members of ANTRUK’s Science or Education Committee.
The UK-based charity has adopted a scoring system developed by the Medical Research Council for use by independent referees, with the top scoring applications to be shortlisted and then prioritised by the charity’s grants panel.
“These grants will fund essential research in both basic and applied sciences to help prevent another global pandemic, this time caused by antibiotic resistant bacteria,” said Colin Garner, chief executive of ANTRUK
“Supporting UK university academics in their research into antibiotics and antibiotic resistance is a key objective for ANTRUK, and we are delighted that the 2021 grants will be the largest yet for the charity. We will offer up to seven research grants to fund projects that will help save modern medicine through better antibiotic use and stewardship,” he added.
Applicants working in higher education, not-for-profit institutes and non-governmental organisations based in the UK are eligible to apply for the grants.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026